Shabram P[au] - Search Results

Year	Number of Results
1995	1
1997	2
1998	1
2000	2
2001	2
2002	1
2003	1
2014	1
2015	1
2021	3
2022	1
2023	0

1

Development of Pediatric Dosage Preparation for CVD 103-HgR Live Oral Cholera Vaccine.

Duffin RP, Delbuono M, Nishioka K, Shabram P, Patel AA. Duffin RP, et al. Among authors: shabram p. Am J Trop Med Hyg. 2022 Jul 5;107(2):388-92. doi: 10.4269/ajtmh.21-1317. Online ahead of print. Am J Trop Med Hyg. 2022. PMID: 35895408

2

Home Administration of CVD 103-HgR: A Live Attenuated Oral Cholera Vaccine.

Duffin RP, Delbuono M, Chew L, Johnstone J, Niedan V, Schwarz P, Shabram P, Patel AA. Duffin RP, et al. Among authors: shabram p. Am J Trop Med Hyg. 2021 Mar 1;104(4):1232-1240. doi: 10.4269/ajtmh.20-1223. Am J Trop Med Hyg. 2021. PMID: 33646977 Free PMC article.

3

Zika virus-like particle vaccine protects AG129 mice and rhesus macaques against Zika virus.

Vang L, Morello CS, Mendy J, Thompson D, Manayani D, Guenther B, Julander J, Sanford D, Jain A, Patel A, Shabram P, Smith J, Alexander J. Vang L, et al. Among authors: shabram p. PLoS Negl Trop Dis. 2021 Mar 12;15(3):e0009195. doi: 10.1371/journal.pntd.0009195. eCollection 2021 Mar. PLoS Negl Trop Dis. 2021. PMID: 33711018 Free PMC article.

4

CVD 103-HgR live, attenuated cholera vaccine strain viability in drinking waters from the US and Europe.

Duffin RP, Delbuono M, Nishioka K, Shabram P, Patel AA. Duffin RP, et al. Among authors: shabram p. Sci Rep. 2021 Jun 23;11(1):13188. doi: 10.1038/s41598-021-92182-3. Sci Rep. 2021. PMID: 34162914 Free PMC article.

5

Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization.

Maxfield LF, Abbink P, Stephenson KE, Borducchi EN, Ng'ang'a D, Kirilova MM, Paulino N, Boyd M, Shabram P, Ruan Q, Patel M, Barouch DH. Maxfield LF, et al. Among authors: shabram p. Clin Vaccine Immunol. 2015 Nov;22(11):1166-75. doi: 10.1128/CVI.00510-15. Epub 2015 Sep 16. Clin Vaccine Immunol. 2015. PMID: 26376928 Free PMC article.

6

Multiplicity of infection/multiplicity of confusion.

Shabram P, Aguilar-Cordova E. Shabram P, et al. Mol Ther. 2000 Nov;2(5):420-1. doi: 10.1006/mthe.2000.0212. Mol Ther. 2000. PMID: 11082315 Free article. No abstract available.

7

Sensitivity and reproducibility in adenoviral infectious titer determination.

Nyberg-Hoffman C, Shabram P, Li W, Giroux D, Aguilar-Cordova E. Nyberg-Hoffman C, et al. Among authors: shabram p. Nat Med. 1997 Jul;3(7):808-11. doi: 10.1038/nm0797-808. Nat Med. 1997. PMID: 9212113 No abstract available.

8

Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles.

Shabram PW, Giroux DD, Goudreau AM, Gregory RJ, Horn MT, Huyghe BG, Liu X, Nunnally MH, Sugarman BJ, Sutjipto S. Shabram PW, et al. Hum Gene Ther. 1997 Mar 1;8(4):453-65. doi: 10.1089/hum.1997.8.4-453. Hum Gene Ther. 1997. PMID: 9054520

9

Evaluation of a549 as a new vaccine cell substrate: digging deeper with massively parallel sequencing.

Shabram P, Kolman JL. Shabram P, et al. PDA J Pharm Sci Technol. 2014 Nov-Dec;68(6):639-50. doi: 10.5731/pdajpst.2014.01027. PDA J Pharm Sci Technol. 2014. PMID: 25475639

10

Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy.

Ramachandra M, Rahman A, Zou A, Vaillancourt M, Howe JA, Antelman D, Sugarman B, Demers GW, Engler H, Johnson D, Shabram P. Ramachandra M, et al. Among authors: shabram p. Nat Biotechnol. 2001 Nov;19(11):1035-41. doi: 10.1038/nbt1101-1035. Nat Biotechnol. 2001. PMID: 11689848

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results